Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    dailyadda
    dailyadda

    GSK Pharma Q3 Review: Motilal Oswal Lowers Target Price Despite Profit Beat — Here's Why

    19 hours ago

    Considering the limited upside from current levels, the brokerage reiterates its Neutral stance on GSK Pharma.

    Considering the limited upside from current levels, the brokerage reiterates its Neutral stance on GSK Pharma.
    Click here to Read More
    Previous Article
    Q3 Results Today: Britannia, Eicher Motors, Grasim, Titan Among Over 300 Companies To Declare Earnings On Feb. 10
    Next Article
    "Apne Liye Kuch Nahi Kiya": Mohsin Naqvi's Face Saving Act Before T20 World Cup Boycott U-Turn

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment